2022 Tutorial on Neoplastic Hematopathology
- Identify how to evaluate and respond to diagnostic problems that arise in neoplastic hematopathology;
- State how to utilize recent advances in the classification of hematopoietic tumors;
- Discuss how to interpret and apply immunologic and molecular genetic findings in the diagnosis of neoplastic hematologic disease;
- Describe how to implement the most recent classification of hematologic neoplasms;
- Recall new discoveries that might impact future classifications of hematologic neoplasms;
- Analyze the prognostic and therapeutic significance of new molecular genetic markers of these tumors.
*Agenda subject to change.
Please contact Thelma Wright via e-mail here.
ACCESSIBILITY The University of Chicago is committed to providing equal access appropriate to need and circumstances and complies fully with legal requirements of the Americans with Disabilities Act. If you are in need of special accommodation, please contact our office at 773-834-2555 or via email at firstname.lastname@example.org.
The University of Chicago reserves the right to cancel or postpone this conference due to unforeseen circumstances. In the unlikely event this activity must be cancelled or postponed, the registration fee will be refunded; however, The University of Chicago is not responsible for any related costs, charges, or expenses to participants, including fees assessed by airline/travel/lodging agencies.
Donald West and Mary Elizabeth King Professor
University of Chicago
ASSOCIATE COURSE DIRECTOR
Professor and Chair, Department of Pathology
Texas Tech University
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone in a position to control the content of an education activity to disclose all financial relationships with any ineligible companies. This includes any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if a financial relationship, in any amount, exists between the person in control of content and an ineligible company during the past 24 months, and the content of the education is related to the products of an ineligible company with whom the person has a financial relationship. Mechanisms are in place to identify and mitigate any relevant financial relationships prior to the start of the activity.
Additionally, he University of Chicago Pritzker School of Medicine requires authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 35.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Board of Pathology Lifelong Learning (CME) Credit
This activity has been registered to offer credit in the American Board of Pathology’s Continuing Certification program. Successful completion of this activity, which includes participation in the evaluation component, enables the participant to earn up to 35.75 CME credits. Participants will earn credits equivalent to the amount of AMA PRA Category 1 Credits™ claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABPath Lifelong Learning (CME) credit.
Other Health Professional Credit
Other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing.
EXHIBIT OPPORTUNITIES AVAILABLE!
Enter the discount code during the registration process to receive the early rate!
|Before 12/25/2021||Discount Code||After 12/25/2021|
Physicians in Training
CANCELLATION POLICY: If you cancel your participation in this conference, your registration fee less a $150 administrative fee will be refunded when written notification is received by January 3, 2022. No refunds will be made after January 3, 2022.
At the end of the course, the credit claiming process will unlock. Return to this page and click on "Complete Activity" to proceed.
Please Note: Requests to claim MOC Part II credit must be made within one month to report to ABPath. Requests to claim AMA PRA Category 1 Credit™ after three months will be subject to additional fees.